Literature DB >> 16111745

A new in vivo screening model for posterior spinal bone formation: comparison of ten calcium phosphate ceramic material treatments.

Clayton E Wilson1, Moyo C Kruyt, Joost D de Bruijn, Clemens A van Blitterswijk, F Cumhur Oner, Abraham J Verbout, Wouter J A Dhert.   

Abstract

This study presents a new screening model for evaluating the influence of multiple conditions on the initial process of bone formation in the posterior lumbar spine of a large animal. This model uses cages designed for placement on the decorticated transverse process of the goat lumbar spine. Five conduction channels per cage, each be defined by a different material treatment, are open to both the underlying bone and overlying soft tissue. The model was validated in ten adult Dutch milk goats, with each animal implanted with two cages containing a total of ten calcium phosphate material treatments according to a randomized complete block design. The ten calcium phosphate ceramic materials were created through a combination of material chemistry (BCP, TCP, HA), sintering temperature (low, medium, high), calcination and surface roughness treatments. To monitor the bone formation over time, fluorochrome markers were administered at 3, 5 and 7 weeks and the animals were sacrificed at 9 weeks after implantation. Bone formation in the conduction channels was investigated by histology and histomorphometry of non-decalcified sections using traditional light and epifluorescent microscopy. According to both observed and measured bone formation parameters, materials were ranked in order of increasing magnitude as follows: low sintering temperature BCP (rough and smooth) approximately medium sintering temperature BCP approximately = TCP > calcined low sintering temperature HA > non-calcined low sintering temperature HA > high sintering temperature BCP (rough and smooth) > high sintering temperature HA (calcined and non-calcined). These results agree closely with those obtained in previous studies of osteoconduction and bioactivity of ceramics thereby validating the screening model presented in this study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111745     DOI: 10.1016/j.biomaterials.2005.06.041

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Porous hydroxyapatite and biphasic calcium phosphate ceramics promote ectopic osteoblast differentiation from mesenchymal stem cells.

Authors:  Lingli Zhang; Nobutaka Hanagata; Megumi Maeda; Takashi Minowa; Toshiyuki Ikoma; Hongsong Fan; Xingdong Zhang
Journal:  Sci Technol Adv Mater       Date:  2009-07-10       Impact factor: 8.090

2.  Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro.

Authors:  Janice R Overman; Elisabet Farré-Guasch; Marco N Helder; Christiaan M ten Bruggenkate; Engelbert A J M Schulten; Jenneke Klein-Nulend
Journal:  Tissue Eng Part A       Date:  2012-11-16       Impact factor: 3.845

3.  The thermal stability of hydroxyapatite in biphasic calcium phosphate ceramics.

Authors:  R W N Nilen; P W Richter
Journal:  J Mater Sci Mater Med       Date:  2007-09-25       Impact factor: 3.896

4.  Feasibility, tailoring and properties of polyurethane/bioactive glass composite scaffolds for tissue engineering.

Authors:  Francesco Baino; Enrica Verné; Chiara Vitale-Brovarone
Journal:  J Mater Sci Mater Med       Date:  2009-06-02       Impact factor: 3.896

5.  Scaffolds with a standardized macro-architecture fabricated from several calcium phosphate ceramics using an indirect rapid prototyping technique.

Authors:  C E Wilson; C A van Blitterswijk; A J Verbout; W J A Dhert; J D de Bruijn
Journal:  J Mater Sci Mater Med       Date:  2010-11-11       Impact factor: 3.896

6.  Regenerating articular tissue by converging technologies.

Authors:  Lorenzo Moroni; Doreen Hamann; Luca Paoluzzi; Jeroen Pieper; Joost R de Wijn; Clemens A van Blitterswijk
Journal:  PLoS One       Date:  2008-08-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.